Genalyte

5 known investors

Genalyte is developing Merlin, an automated diagnostic device that processes blood samples on-site and returns lab results within minutes while the patient waits. Its CloudLab platform integrates with electronic medical record (EMR) systems to route and deliver results automatically at the point of care.

Digital HealthHardwareMedical Devicesin /genalyte-inc @Genalyte

Investors · 5

BioBritLa Jolla

Claremont Creek VenturesOakland · $500K – $3Mvia Brad Webb · led

FusionX VenturesSan Diego

IPD CapitalAventura

TEL Venture Capital, Inc.Fremont

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2013	$999.2K
National Institutes of Health (NIH)National Institutes of Health	Phase I	2012	$523.5K
National Institutes of Health (NIH)National Institutes of Health	Phase I	2011	$199.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.